CAN BE
ALTERNATIVE
INVESTMENT

Apply for funding to be hosted at NCI to develop international collaborations and gain skills to underpin the next phase of your cancer research career.
You must be an early or mid-career researcher and your research can focus on any area within MRC’s or NIHR’s remit.
Opening date 2 Apr 2024, 12:00AM
Closing date 2 Aug 2024, 01:00PM
This funding opportunity is for UK-based early or mid-career researchers.
You should be looking to obtain training, develop skills and experience, and establish international collaborations with NCI researchers, towards supporting your transition to independence in cancer research.
You are likely to have a background in cancer research. If you do not come from a cancer research background, you are eligible. However, you will be expected to demonstrate how the funding opportunity will enhance your skills and facilitate ongoing cancer research and sustained collaborations beyond the end of the award.
Standard UK Research and Innovation (UKRI) eligibility criteria apply and specific NIHR eligibility criteria is outlined in the guidance notes on the NIHR website.
We invite applications from individuals at eligible organisations, in accordance with standard UKRI and NIHR practice.
Before applying for funding, check if you are eligible for research and innovation funding.
You should:
For clinical academic applications, you must have completed the relevant pre-registration training.
You do not need to currently hold an MRC or NIHR fellowship and there are no eligibility rules based on years of postdoctoral experience.
We welcome applications from all early or mid-career researchers. However, you will be required to demonstrate that you are at an appropriate career stage and describe how this award will support your trajectory to becoming a future leader in your field.
The ‘early postdoctoral’ and ‘transition to independence’ career stages in the MRC applicant skills and experience criteria describe target career stages well suited to these awards.
You must clearly demonstrate that you have the potential, and are on a trajectory, to become a future leader in your area of research.
You must describe how this award will provide significant support towards becoming a researcher leader.
Early postdoctoral applicants particularly need to provide evidence of productivity and potential to lead independent research. For example, as demonstrated by critical contributions to independent or collaborative research outputs and articulate how this award will support a step change in their career trajectory towards independence and leadership.
You must propose a clear and detailed training and development plan that will maximise the opportunity provided through the scheme to work with US collaborators. Plans must be supported by your host institution and mentors.
The ‘transition to independence’ is the primary career stage being targeted and while not ineligible, individuals that are already established as an independent researcher are not the priority career stage for this scheme.
If an established researcher applies, a clear justification should be provided to explain why the support is required and why it is not already available through the host organisation.
You should consider whether this award will provide significant support on your career trajectory.
There are no eligibility rules based on whether you currently hold a permanent or open-ended academic position or job role. However, you must be based in the UK and have the support of your UK host organisation for the duration of the proposed award.
We encourage you to get in touch if you are unsure about your eligibility.
We’re looking to support talented individuals to visit or be hosted by research groups at NCI over a duration of six to 12-months.
NCI is the largest of NIH’s 27 institutes and centres, and it consists of more than 300 laboratories and research groups.
NCI is located on the main NIH campus in Bethesda, Maryland, and in the surrounding area of Rockville and Frederick, Maryland.
Eligible US research groups are directly funded by the NCI at the Center for Cancer Research (CCR) or the Division of Cancer Epidemiology and Genetics (DCEG). For more information about eligible NCI research groups, please see:
Your application should support the establishment of new collaborations, or the substantial development of existing collaborations, with researchers at NCI.
We welcome you to approach potential NCI hosts directly if you have existing contacts, or are clear on who you wish to approach.
If you are unsure which research groups may be best suited to your interests, support and ‘match making’ can be facilitated by contacting NCI central contacts.
An email inquiry should be sent to both Erika Ginsburg (ginsbure@mail.nih.gov) and Jackie Lavigne (lavignej@nih.gov) and include the following information:
If you require matchmaking support, you should get in touch as early as possible and no later than 7 June 2024.
Once matching with a research group has been undertaken by NCI, you will be informed via email of the proposed research group and provided with their contact details.
You are required to work with your prospective NCI host to develop your application, discussing the opportunities and activities that will be on offer.
As part of the application, the NCI host is required to provide a letter of support, which you will upload as part of your application (see ‘Statement of support’).
Your application can focus on any area of cancer research within MRC’s or NIHR’s remit, or both, across biomedical and health research. For example, discovery and basic disease biology, through to translational, clinical and applied cancer research.
Find out about MRC’s strategy, remit and programmes.
Find out about NIHR’s academy remit for personal awards.
We are particularly keen to see applications that develop skills and experience in the following areas that align with priority opportunities identified during the UK-US Cancer Summit:
In your application, you must clearly demonstrate:
These awards are to fund visits to the US across a six to 12-month period with the format of these visits being flexible. For example, you may choose to visit once for an extended duration or make several shorter visits.
You have MRC’s and NIHR’s support if you wish to combine this award with caring or family responsibilities. Appropriate costs to support this can be included within the application.
You must spend substantial time within the duration of the award visiting eligible research group or groups at NCI CCR or DCEG, or both.
The time spent overseas must accommodate the specific training and skills development aims of each application and your individual circumstances.
While virtual interactions will support ongoing development and skills over the duration of the award, we expect you to take advantage of and prioritise the opportunity for in-person visits.
In your application, you must clearly justify:
Full economic costs are not covered by this award. All costs will be supported at 100%.
Awards will provide funding for:
Both the UK host (applicant employer) and NCI host (organisation being visited) should provide applicant-specific letters of support. Letters should outline appropriate commitment to supporting skills development, training needs and long-term career goals.
UK host (applicant employer) commitment includes:
NCI host (organisation being visited) commitment includes:
You must ensure that all proposed research, both that in the UK and in the US, will comply with the standard principles and expectations for UK research using animals, human participants and human tissue (including stem cells).
More detail on expectations is included in the guidance document on the NIHR website for this funding opportunity. For example, additional joint letters of support accompanying the application will be required when human or human tissue or animal research is proposed, and animal welfare standards should be consistent with the principles of UK legislation.
UK Research and Innovation (UKRI) is committed in ensuring that effective international collaboration in research and innovation takes place with integrity and within strong ethical frameworks.
Trusted research and innovation (TR&I) is a UKRI work programme designed to help protect all those working in our thriving and collaborative international sector by enabling partnerships to be as open as possible, and as secure as necessary.
Our TR&I principles set out UKRI’s expectations of organisations funded by UKRI in relation to due diligence for international collaboration.
As such, applicants for UKRI funding may be asked to demonstrate how their proposed projects will comply with our approach and expectation towards TR&I, identifying potential risks and the relevant controls you will put in place to help proportionately reduce these risks.
Further guidance and information about TR&I, including where you can find additional support.
All applications must be completed and submitted using the NIHR online application system.
You can find guidance on completing your application in the guidance notes on the NIHR website.
We recommend you start your application early.
Your host organisation will also be able to provide advice and guidance.
NIHR must receive your application by 2 August 2024 at 1:00pm UK time.
You will not be able to apply after this time. Please leave enough time for your application to pass through your organisation’s submission route before this date.
You should ensure you are aware of and follow any internal institutional deadlines that may be in place, for both UK and US partners.
Your application must also include the following attachments:
More information is provided in the guidance notes on the NIHR website for this funding opportunity.
For help and advice on costings and writing your application please contact your research office in the first instance.
This funding opportunity is jointly funded by MRC and NIHR with in-kind support from NCI.
Queries related to funding opportunity scope and purpose may be addressed to any of the following contacts.
Email: cancer@mrc.ukri.org
Include ‘UK US Cancer DSE’ in the subject line.
We aim to respond within five working days.
Email: academy-awards@nihr.ac.uk
Telephone: 0113 532 8410
The funding opportunity is administered through the NIHR Academy and NIHR will be best placed to address queries related to applying.
0113 532 8410
Monday to Friday 9:00am to 5:00pm US time
A webinar will be hosted on 24 April 2024, 2:00pm to 3:00pm UK time to provide information and address questions from potential applicants.
Value Ad helps new businesses save 50% to 80% on essential services like marketing and
development. These savings act as an alternative investment, fueling growth.
Service providers gain valuable initial customers, helping them grow and attract investment.
It's a win-win for everyone!
This App/website is not affiliated with any government agency. We collect and organize information from publicly available government websites and provide direct links to these official sources.
For accurate details and to apply for grants or loans, please visit the relevant government websites linked within the App/website.
What is Value Ad?
Value Ad is an innovative policy designed to foster a mutually beneficial relationship between two key groups: new businesses and service providers. This policy helps startups save significantly on essential services while enabling service providers to gain valuable traction and growth opportunities.
How is it a Win-Win Deal?
For New Businesses:
Cost Savings: Startups can save 50% to 80% on essential services such as website development and marketing. This means they don’t need to invest heavily upfront, making it easier to launch and grow their business.
Alternative Investment: The money saved through these discounts can be reinvested into other critical areas of the business, acting as an alternative investment that fuels further growth and development.
For Service Providers:
Initial Customer Base: Service providers, often tech startups themselves, can attract a significant number of initial customers by offering their services at a discounted rate. This helps them build traction and demonstrate value, which is crucial for attracting venture capital (VC) funding and other opportunities.
Marketing Efficiency: By providing affordable services, service providers do not need to spend heavily on marketing to acquire new customers. The discounted services themselves become a powerful marketing tool, bringing in customers who can spread the word and enhance the provider’s reputation.
Growth and Expansion: Attracting more customers through Value Ad helps service providers expand their client base and build long-term relationships, which can lead to increased revenue and business growth.
Alternative Investment for New Businesses:
For new businesses, the significant cost savings achieved through the Value Ad policy effectively serve as an alternative investment. Instead of spending large amounts on website development and marketing, they can leverage the affordable services provided by service providers. The saved funds can be redirected into other strategic areas of the business, enhancing overall growth and sustainability.
Benefits for Service Providers:
Service providers benefit from the Value Ad policy by gaining access to a ready pool of new customers who are drawn by the discounted rates. This initial customer base is crucial for:
Building Traction: Demonstrating product or service viability to potential investors.
Securing Funding: Enhanced customer traction and a growing user base can make the service provider more attractive to venture capitalists and other funding sources.
Market Penetration: Establishing a presence in the market quickly and efficiently without heavy marketing expenditures.
In Summary:
Value Ad is a strategic policy designed to create a win-win scenario for both new businesses and service providers. By offering significant discounts on essential services, startups can save and reinvest those savings, while service providers gain crucial initial customers and market traction. This mutually beneficial arrangement supports the growth and success of both groups, making Value Ad a powerful tool for business development and investment.
We use cookies and similar technologies that are necessary to operate the website.Please read our cookie policy.
We use cookies and similar technologies that are necessary to operate the website. Additional cookies are only used with your consent. We use the additional cookies to perform analyses of website usage and to check marketing measures for their efficiency. These analyses are carried out to provide you with a better user experience on the website. You are free to give, deny, or withdraw your consent at any time by using the "cookie settings" link at the bottom of each page. You can consent to our use of cookies by clicking "Agree". For more information about what information is collected and how it is shared with our partners, please read our cookie policy.